Assistant Professor of Medicine at Johns Hopkins. I’m a clinician and researcher whose interests include addiction, health technology and implementation science
Baltimore, MD
Joined August 2015
- Tweets102
- Following349
- Followers230
- Likes18
Will Garneau retweeted
For hospitalized patients with opioid use disorder, risk of patient-directed discharge (PDD) was reduced by 29% with each additional 10mg of methadone given within the first 24 hours of care.
ja.ma/4rYPtVK
ALT Four sets of graphs labeled A to D show 'Incidence of PDD, %' vs. 'Cumulative methadone dose, mg' for 24-h, 48-h, and 72-h cohorts. Graphs depict incidence trends relative to methadone dosage at 48h, 72h, 96h, and overall.
We recently shared our findings describing differences in clinical evaluation for mpox during the 2022 epidemic. Our study examined adherence to CDC guidelines for the care of persons with suspected mpox.
1
5
399
Will Garneau retweeted
WINNER! Milton W. Hamolsky Awards are presented to junior faculty whose abstracts are "the most outstanding among those submitted to the national meeting."
Congrats, Dr. Gupta.🏆 #SGIM24 #HopkinsGIM
ALT Photo of the screen at SGIM 2024 announcing the winners of the Milton W. Hamolsky awards.
Dr. @rgupta729's, a finalist for the Milton W. Hamolsky Awards at #SGIM24, presents an analysis helping us understand the impact of insurance companies' prior authorization policies on outpatient providers. #HopkinsGIM
ALT Photo of a PowerPoint slide of Dr. Ravi Gupta's presentation.
ALT Dr. Ravi Gupta presents at #SGIM24.
Will Garneau retweeted
New in @JHospMedicine: IM residents were twice as likely to sit at the bedside on units w/ folding chairs. Patients were also more likely to say that residents spent enough time at the bedside + checked for understanding on units with chairs 🪑. shmpublications.onlinelibrar…
Will Garneau retweeted
When my Medicaid patients learn that I study the role of psychedelic therapies in SUD Tx, they often ask when they'll be available. The answer: it depends. Grateful to share this @JAMANeuro perspective on aligning psychedelics research with health equity.
jamanetwork.com/journals/jam…
Will Garneau retweeted
Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox
🔓 Open Access
bit.ly/3GRj6mV
via @willgarneau
Will Garneau retweeted
Study in @OFIDJournal (bit.ly/3RtlBBV) by @JHMed_ID, @JHUPath, @JohnsHopkinsDOM & @HopkinsMedicine Emerg Med shows immunosuppression is risk factor for hospitalization with #mpox. Infection in vulnerable populations can be fatal; merits intensive monitoring & treatment.
Yesterday we published a study of outcomes for patients with mpox infections during the 2022 outbreak. Immunosuppression was a strong risk factor for hospitalization.
Thank you to the research team at Johns Hopkins. I look forward to more research to inform practice in order to best serve patients
1
197
Will Garneau retweeted
Congratulations to one of our great Hospitalists @ANiranjanAzadi who was just named Physician of the Year for the @SocietyHospMed MD Chapter!
